During Arendalsuka 2019, we arranged a breakfast meeting on the development of cancer treatments of the future, together with LMI and Kreftforeningen. Arendalsuka has become an important arena for those who want to improve aspects of Norwegian society. We were there this year to meet key players to accelerate the development of cancer treatments. Our […]
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 388 entries.
Entries by oslocancer
Immunitrack has been awarded a grant from Eurostars to develop their prediction tool for cancer vaccines.
The Japanese tech giant NEC Corporation has acquired OncoImmunity AS.
Oslo Cancer Cluster Incubator collaborates with partners in Sweden, Norway and Finland to help life science professionals learn from their neighbours.
We proudly present the new members that have joined our organisation during the second quarter of 2019.
We are happy to welcome three new members to the board of Oslo Cancer Cluster. Find out what they had to say about entering their new positions.
SINTEF is looking for new partners to develop methodology for cancer immunotherapy.
Students got to try DNA profiling at a work placement at Thermo Fisher Scientific, arranged by Oslo Cancer Cluster and Ullern Upper Secondary School.
The Nobel Laureate Dr James Allison and oncologist Dr Padmanee Sharma will become strategic advisors for our member Lytix BioPharma.
Oslo Cancer Cluster and its international partners organised the International Cancer Cluster Showcase (ICCS) on 3 June in Philadelphia.
Contact Team >
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.